Literature DB >> 8761481

Ligand-dependent enhancement of human antithrombin gene expression by retinoid X receptor alpha and thyroid hormone receptor beta.

R W Niessen1, F Rezaee, P H Reitsma, M Peters, J J de Vijlder, A Sturk.   

Abstract

We studied potential modulators of antithrombin gene expression. A putative hormone response element (HRE) was identified by sequence similarity analysis of the antithrombin promoter, situated between nucleotides -92 and -54 relative to the transcription start site. This HRE contains three hexa-nucleotide motifs with an AGGTCA consensus, which are potential targets of members of the steroid/thyroid superfamily of nuclear receptors. Stimulation of the hepatoma cell line HepG2 with the receptor ligands L-3,5,3'-tri-iodothyronine, all-trans retinoic acid, or their combination, increased production of antithrombin into the culture medium by 1.3-, 1.6-, and 2.0-fold, respectively. In contrast, the receptor ligand 1,25-dihydroxy-cholecalciferol[1,25-(OH)2VitD3] did not influence antithrombin production. Analysis of promoter chloramphenicol acetyl-transferase (CAT) constructs, showed that the first 86 bp of the antithrombin promoter region are sufficient for basal transcription. The DNA length polymorphism of 32 bp or 108 bp, located upstream of position -276, did not influence anti-thrombin promoter activity. The antithrombin promoter activity dropped to background values when deleting the region -97/-49 of promoter fragment -453/+57. Transactivation of the antithrombin promoter by retinoid X receptor alpha (RXR alpha) (5-7-fold) or thyroid hormone receptor beta (TR beta) (4-5-fold) was only observed when at least -167/+57 bp of the promoter region is present in CAT constructs, and when the appropriate ligand of the nuclear receptor was added. This transactivation was not observed upon deletion of the antithrombin promoter region -97/-49. With three copies of the antithrombin promoter fragment -109/-42 in front of the thymidine kinase minimal promoter, transactivation was only obtained with RXR alpha, and not with TR beta. In conclusion, these results indicate that the ligand-dependent enhancement of antithrombin gene expression is regulated by RXR alpha as well as by TR beta. Transactivation of antithrombin gene expression by RXR alpha and TR beta appears to be dependent upon the presence of promoter region up to nucleotide -167. The HRE segment (-109/-42) only confers RXR alpha responsiveness to a heterologous promoter. Further study is needed to unravel the exact nature of this HRE and its 5'-flanking sequences.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761481      PMCID: PMC1217617          DOI: 10.1042/bj3180263

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  52 in total

1.  The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors.

Authors:  A M Näär; J M Boutin; S M Lipkin; V C Yu; J M Holloway; C K Glass; M G Rosenfeld
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

2.  A retinoic acid-responsive element in the apolipoprotein AI gene distinguishes between two different retinoic acid response pathways.

Authors:  J N Rottman; R L Widom; B Nadal-Ginard; V Mahdavi; S K Karathanasis
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

3.  RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements.

Authors:  V C Yu; C Delsert; B Andersen; J M Holloway; O V Devary; A M Näär; S Y Kim; J M Boutin; C K Glass; M G Rosenfeld
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

4.  A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR.

Authors:  D J Mangelsdorf; K Umesono; S A Kliewer; U Borgmeyer; E S Ong; R M Evans
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

5.  Mouse retinoic acid receptor alpha 2 isoform is transcribed from a promoter that contains a retinoic acid response element.

Authors:  P Leroy; H Nakshatri; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

6.  Characterization of DNA binding and retinoic acid binding properties of retinoic acid receptor.

Authors:  N Yang; R Schüle; D J Mangelsdorf; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

7.  9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha.

Authors:  A A Levin; L J Sturzenbecker; S Kazmer; T Bosakowski; C Huselton; G Allenby; J Speck; C Kratzeisen; M Rosenberger; A Lovey
Journal:  Nature       Date:  1992-01-23       Impact factor: 49.962

8.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

Authors:  R A Heyman; D J Mangelsdorf; J A Dyck; R B Stein; G Eichele; R M Evans; C Thaller
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

9.  Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.

Authors:  M Leid; P Kastner; R Lyons; H Nakshatri; M Saunders; T Zacharewski; J Y Chen; A Staub; J M Garnier; S Mader
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

10.  RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors.

Authors:  T H Bugge; J Pohl; O Lonnoy; H G Stunnenberg
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

View more
  3 in total

1.  Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels.

Authors:  Ana I Antón; Raúl Teruel; Javier Corral; Antonia Miñano; Irene Martínez-Martínez; Adriana Ordóñez; Vicente Vicente; Beatriz Sánchez-Vega
Journal:  Haematologica       Date:  2009-02-19       Impact factor: 9.941

2.  Dexamethasone Preconditioning in Cardiac Procedures Reduces Decreased Antithrombin Activity and Is Associated to Beneficial Outcomes: Role of Endothelium.

Authors:  Vicente Muedra; Lucrecia Moreno; Vicente Rodilla; Cristina Arce; Fermi Montó; Águeda Blázquez; Paloma Pérez; Pilar D'Ocón
Journal:  Front Pharmacol       Date:  2018-09-25       Impact factor: 5.810

3.  Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency.

Authors:  Mara Toderici; María Eugenia de la Morena-Barrio; José Padilla; Antonia Miñano; Ana Isabel Antón; Juan Antonio Iniesta; María Teresa Herranz; Nuria Fernández; Vicente Vicente; Javier Corral
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.